Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 02/12/2024 GMT
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.39M 1.29M 1.18M 2.22M 150M 2.24M 15.65M 6.07M 76.54M 5.85M 5.72M 246M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.78M -26.82M -24.45M -46.13M -3.12B -46.57M -325M -126M -1.59B -122M -119M -5.11B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 89.8 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 31/03/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dan Kisner
BRD | Director/Board Member | 79 | 06/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 30/11/2017 |
Xin Nakanishi
BRD | Director/Board Member | 64 | 31/10/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.45% | 1.56M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -2.61% | -3.11% | +48.95% | +99.11% | 39.05B | |
| Weighted average by Cap. | +0.12% | -0.84% | +58.76% | +129.91% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.32M 1.23M 1.13M 2.12M 143M 2.14M 14.96M 5.8M 73.17M 5.59M 5.47M 235M | 785K 698K 650K 593K 1.12M 75.6M 1.13M 7.88M 3.06M 38.55M 2.95M 2.88M 124M |
| Net income | -44.17M -39.26M -36.59M -33.36M -62.93M -4.25B -63.53M -444M -172M -2.17B -166M -162M -6.97B | -39.48M -35.09M -32.71M -29.82M -56.25M -3.8B -56.78M -396M -154M -1.94B -148M -145M -6.23B |
| Net Debt | -63.64M -56.56M -52.72M -48.06M -90.66M -6.13B -91.52M -639M -248M -3.13B -239M -234M -10.04B | -33.94M -30.16M -28.12M -25.63M -48.35M -3.27B -48.81M -341M -132M -1.67B -127M -125M -5.36B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
